Valuation: AcuCort AB

Market Cap 15Cr 1.53Cr 1.33Cr 1.25Cr 1.14Cr 2.15Cr 146.12Cr 2.18Cr 5.72Cr 73Cr 5.76Cr 5.63Cr 243Cr P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 12Cr 1.25Cr 1.08Cr 1.02Cr 92.9L 1.75Cr 119.05Cr 1.78Cr 4.66Cr 59Cr 4.69Cr 4.59Cr 197.99Cr EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day-0.96%
1 week-4.31%
Current month-4.01%
1 month-4.31%
3 months-5.76%
6 months-31.12%
Current year+3.67%
1 week 0.6
Extreme 0.604
0.65
1 month 0.53
Extreme 0.53
0.66
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.26
5 years 0.33
Extreme 0.327
4.98
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 09/08/2020
Corporate Officer/Principal 53 14/10/2025
Director TitleAgeSince
Director/Board Member 68 08/02/2017
Chairman 63 01/01/2018
Director/Board Member 79 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-4.31%-6.89%-43.45% 1.55Cr
-0.87%-1.47%-25.06%-27.57% 1.6TCr
+0.71%-1.67%-28.83%-36.74% 743.97Cr
+0.78%-2.60%-26.38%-8.13% 603.3Cr
-0.66%-1.01%-8.29%-31.89% 406.21Cr
-0.73%+0.16%-22.79%-41.16% 331.94Cr
+1.06%+0.48%-41.34%-22.86% 310.06Cr
-1.92%-6.38%+1.59%-39.00% 308.02Cr
+0.06%-4.37%-14.55%+3.29% 261.17Cr
-2.54%-4.20%+88.49% - 256.45Cr
Average -0.52%-2.91%-8.40%-27.50% 482.32Cr
Weighted average by Cap. -0.41%-2.54%-16.97%-26.56%

Financials

2024 2025
Net sales 77.17L 8L 7L 7L 6L 11.39L 7.73Cr 11.54L 30.29L 3.86Cr 30.48L 29.82L 13Cr 66.83L 7L 6L 6L 5L 10L 6.7Cr 10L 26.23L 3.35Cr 26.39L 25.82L 11Cr
Net income -1.74Cr -18.3L -15.88L -14.87L -13.6L -25.68L -17Cr -26.02L -68.28L -8.71Cr -68.71L -67.22L -29Cr -2.62Cr -27.55L -23.91L -22.39L -20.48L -38.66L -26Cr -39.16L -1.03Cr -13Cr -1.03Cr -1.01Cr -44Cr
Net Debt -27.72L -3L -3L -2L -2L -4L -2.78Cr -4L -10.88L -1.39Cr -10.95L -10.71L -4.62Cr -2.7Cr -28.41L -24.66L -23.09L -21.12L -39.87L -27Cr -40.39L -1.06Cr -14Cr -1.07Cr -1.04Cr -45Cr
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
-
Date Price Change Volume
06/26/06 SEK 0.6220 -0.96% 1,30,273
05/26/05 SEK 0.6280 -0.63% 1,65,679
04/26/04 SEK 0.6320 -2.47% 1,24,124
03/26/03 SEK 0.6480 0.00% 72,323
31/26/31 SEK 0.6480 -0.31% 76,097
  1. Stock Market
  2. Stocks
  3. ACUC Stock